PRMT5 drugs for Pancreatic Ductal Adenocarcinoma
2 tracked PRMT5 drugs in the Pancreatic Ductal Adenocarcinoma race. The class explanation lives on the PRMT5 page; the full indication pipeline across every mechanism is on the Pancreatic Ductal Adenocarcinoma page.
1 Phase 1/21 preclinical / unstaged